We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.01%
신규 편입 · 포트폴리오 비중 0.00%
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $36.29 · 7 analysts
Price to sales forward of Jade Biosciences, Inc. – NASDAQ:JBIO - TradingView
Price to sales forward of Jade Biosciences, Inc. – NASDAQ:JBIO TradingView
Janus Henderson holds 6.27M JBIO shares, reporting 10.6% stake (JBIO) - Stock Titan
Janus Henderson holds 6.27M JBIO shares, reporting 10.6% stake (JBIO) Stock Titan
JBIO - Jade Biosciences Inc Latest SEC Filings - Finviz
JBIO - Jade Biosciences Inc Latest SEC Filings Finviz
Jade Biosciences (JBIO) Joins Growth Indexes, Is The Stock Still Undervalued? - simplywall.st
Jade Biosciences (JBIO) Joins Growth Indexes, Is The Stock Still Undervalued? simplywall.st
JBIO - Jade Biosciences Inc Earnings - Finviz
JBIO - Jade Biosciences Inc Earnings Finviz
Jade Biosciences Company Profile & Introduction - Moomoo
Jade Biosciences Company Profile & Introduction Moomoo
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 14. | After market close (AMC) | — | — | — | $0 | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 05. 12. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 05. 11. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2026. 04. 27. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 25. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 16. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 558,474 | $8.62M | 0.01% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 264,315 | $3.71M | 0.01% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 18,251 | $256.43K | 0.00% | — | New position |
| 4 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 16,496 | $254.53K | 0.00% | — | New position |